Pharmacist interactions provide significant benefits for patients with non-small cell lung cancer treated with oral oncolytics.
Jeffrey S. Reichard, PharmD, MS, BCOP, BCPS
Advertisement
Articles by Jeffrey S. Reichard, PharmD, MS, BCOP, BCPS
An in-house specialty pharmacy can provide significant financial gain for health systems by preventing revenue from being diverted to outside pharmacies.
Advertisement
Latest Updated Articles
Strategies for Successful IDN-based Specialty Pharmacy: The Financial PerspectivePublished: August 27th 2019 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Therapeutic Cancer Vaccines: Are We There Yet?
2
Walgreens Strengthens Vaccine Access Through Digital Tools, Pharmacist Education
3
Subcutaneous Amivantamab Shows Promise in EGFR-Mutated Lung Cancer
4
FDA Approves Gazyva for Active Lupus Nephritis
5
